23 results on '"Chen, Ke-Neng"'
Search Results
2. Commentary: The debate between surgery and stereotactic body radiation therapy in treatment of early non–small cell lung cancer: A new connotation is needed for an old topic
3. Commentary: Pay Attention to the Comprehensive Prevention of Acute Lung Injury after Esophagectomy
4. Commentary: Not only safety but also efficacy is required in repeat pulmonary resection for second non–small cell lung cancer
5. Commentary: Endoscopic treatment is the key for superficial esophageal squamous cell neoplasia
6. Commentary: Exquisite surgical techniques and comprehensive oncologic theory are two fundamental requirements of learning lung cancer surgery
7. Results of surgical treatment for primary malignant melanoma of the esophagus: A multicenter retrospective study
8. Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II–IIIA (N1–N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) study
9. Commentary: Pay attention to low-risk populations for lung cancer, but cautiously interpret ground-glass nodules screened by low-dose computed tomography scan
10. Commentary: Esophageal squamous cell carcinoma: A disease requiring more research
11. Thoracic surgeons' insights: Improving thoracic surgery outcomes during the Coronavirus Disease 2019 pandemic
12. Thoracic Surgeons’ Insights: Improving Thoracic Surgery Outcomes During the Coronavirus Disease 2019 Pandemic
13. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers
14. Survival After Induction Chemotherapy and Esophagectomy Is Not Improved by Adjuvant Chemotherapy
15. The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)
16. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus
17. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma
18. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
19. P3.02b-011 Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Patients with Non-Small Cell Lung Carcinoma
20. JCES01.22 Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Patients with Non-Small Cell Lung Carcinoma
21. A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel
22. The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma
23. Exploration of target genes of HOXA13 in esophageal squamous cell carcinoma cell line
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.